Business
Only 40% of Australians want the AstraZeneca vaccine. What could this mean for CSL (ASX:CSL)?
New data reveals that only 40% of Australians are willing to take the AstraZeneca plc (LSE: AZN) COVID-19 vaccine. What, if anything, could this mean for CSL Limited (ASX: CSL)?. The data, released Monday in an Essential Research poll, comes at an inopportune time for the country as a whole, with the inoculation roll-out already delayed.
With CSL being the main manufacturer and distributor of the AstraZeneca vaccine in Australia, it would be interesting to know what the company makes of the latest figures.
Let’s take a closer look at the data.
1 in 5 Australian women refuse to get vaccinated
Since…
-
Noosa News22 hours agoLaidley e-scooter death: Tragic new details after Summah Richards killed in freak accident
-
General23 hours agoMinjee Lee rallies after third-round meltdown to share fifth place at LA Championship
-
General16 hours agoUkraine says Russia has ramped up attacks despite ‘Easter truce’
-
General18 hours agoReason v magical climate thinking – voters have no choice